Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-11-27 | 2020-12-17 | 129050 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-27 | 2021-02-11 | 129045 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2020-11-27 | 2020-12-03 | 129042 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-11-27 | 2020-12-17 | 129039 |
| ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2020-11-27 | 2020-12-17 | 129036 |
| TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2020-11-19 | 2021-01-21 | 128632 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2020-11-19 | 2021-03-04 | 128603 |
| FENTORA | 100MCG | TABLET (EFFERVESCENT) | Resolved | 2020-11-19 | 2021-02-05 | 128600 |
| ACT DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-11-19 | 2021-01-28 | 128597 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-11-12 | 2021-01-28 | 128339 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128336 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128333 |
| TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2020-11-12 | 2021-03-18 | 128330 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 12.5MG | TABLET | Resolved | 2020-11-06 | 2020-12-18 | 128049 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-11-06 | 2021-06-03 | 128045 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128040 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
| ACT AMLODIPINE | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-21 | 128034 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |